Update on ASCCP consensus guidelines for abnormal cervical screening tests and cervical histology

American Family Physician

Volumn 80, Issue 2, 2009, Pages 147-155

  Apgar, Barbara S ^a,b   Kittendorf, Anne L ^a   Bettcher, Catherine M ^a   Wong, Jean ^a,c   Kaufman, Amanda J ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c University of Michigan Medical Center ^*

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADENOCARCINOMA; CANCER SCREENING; COLPOSCOPY; CONSERVATIVE TREATMENT; DISEASE SEVERITY; ENDOMETRIUM CELL; FOLLOW UP; HISTOLOGY; HUMAN; PRACTICE GUIDELINE; PREGNANT WOMAN; REVIEW; SQUAMOUS CELL; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; WART VIRUS;

EID: 67749145819     PISSN: 0002838X     EISSN: 0002838X     Source Type: Journal    
DOI: None     Document Type: Review

References (53)

1. Wright TC Jr, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ, for the ASCCP-Sponsored Consensus Conference. 2001 consensus guidelines for the management of women with cervical cytological abnormalities. JAMA. 2002;287(16):2120-2129.
2. Wright TC Jr, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ, for the 2001 ASCCP-sponsored Consensus Conference. 2001 consensus guidelines for the management of women with cervical cytological abnormalities. J Low Genit Tract Dis. 2002;6(2):127-143.
3. Wright TC Jr, Cox JT, Massad LS, Carlson J, Twiggs LB, Wilkinson EJ, for the American Society for Colposcopy and Cervical Pathology. 2001 consensus guidelines for the management of women with cervical intraepithelial neoplasia. Am J Obstet Gynecol. 2003;189(1):295-304.
4. Wright TC Jr, Cox JT, Massad LS, Carlson J, Twiggs LB, Wilkinson EJ, for the 2001 ASCCP-sponsored consensus workshop. 2001 consensus guidelines for the management of women with cervical intraepithelial neoplasia. J Low Genit Tract Dis. 2003;7(3):154-167.
5. Wright TC Jr, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D, for the 2006 American Society for Colposcopy and Cervical Pathologysponsored consensus conference. 2006 Consensus guidelines for the management of women with abnormal cervical cancer screening tests. Am J Obstet Gynecol. 2007;197(4):346-355.
6. Wright TC Jr, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D, for the 2006 ASCCP-sponsored consensus conference. 2006 Consensus guidelines for the management of women with abnormal cervical screening tests [published correction appears in J Low Genit Tract Dis. 2008;12(3):255]. J Low Genit Tract Dis. 2007;11(4):201-222.
7. Wright TC Jr, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D, for the 2006 American Society for Colposcopy and Cervical Pathology- sponsored consensus conference. 2006 Consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ. Am J Obstet Gynecol. 2007;197(4):340-345.
8. Wright TC Jr, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D, for the 2006 American Society for Colposcopy and Cervical Pathologysponsored consensus conference. 2006 Consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ [published correction appears in J Low Genit Tract Dis. 2008;12(1):63]. J Low Genit Tract Dis. 2007;11(4):223-239.
9. Schiffman M, Herrero R, Desalle R, et al. The carcinogenicity of human papillomavirus types reflects viral evolution. Virology. 2005; 337(1):76-84. (Pubitemid 40725441)
10. U.S. Preventive Services Task Force. Screening for cervical cancer. Rockville, Md.: Agency for Healthcare Research and Quality; January 2003. http://www.ahrq.gov/clinic/uspstf/uspscerv.htm. Accessed March 30, 2009.
11. Vizcaino AP, Moreno V, Bosch FX, et al. International trends in incidence of cervical cancer: II. Squamous-cell carcinoma. Int J Cancer. 2000;86(3):429-435. (Pubitemid 30187507)
12. Nanda K, McCrory DC, Myers ER, et al. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann Intern Med. 2000;132(10):810-819. (Pubitemid 30317797)
13. Schneider A, Hoyer H, Lotz B, et al. Screening for high-grade cervical intra-epithelial neoplasia and cancer by testing for high-risk HPV, routine cytology or colposcopy. Int J Cancer. 2000;89(6):529-534.
14. Mayrand MH, Duarte-Franco E, Coutlée F, et al. Randomized controlled trial of human papillomavirus testing versus Pap cytology in the primary screening for cervical cancer precursors: design, methods and preliminary accrual results of the Canadian cervical cancer screening trial (CCCaST). Int J Cancer. 2006;119(3):615-623. (Pubitemid 43955716)
15. Sherman ME, Lorincz AT, Scott DR, et al. Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis. J Natl Cancer Inst. 2003;95(1):46-52.
16. Kjaer S, Høgdall E, Frederiksen K, et al. The absolute risk of cervical abnormalities in high-risk human papillomavirus-positive, cytologically normal women over a 10-year period. Cancer Res. 2006;66(21): 10630-10636. (Pubitemid 44799787)
17. Dunne EF, Unger ER, Sternberg M, et al. Prevalence of HPV infection among females in the United States. JAMA. 2007;297(8):813-819. (Pubitemid 46333946)
18. Bigras G, de Marval F. The probability for a Pap test to be abnormal is directly proportional to HPV viral load: results from a Swiss study comparing HPV testing and liquid-based cytology to detect cervical cancer precursors in 13,842 women. Br J Cancer. 2005;93(5):575-581. (Pubitemid 43080002)
19. Davey DD, Neal MH, Wilbur DC, Colgan TJ, Styer PE, Mody DR. Bethesda 2001 implementation and reporting rates: 2003 practices of participants in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology. Arch Pathol Lab Med. 2004;128(11):1224-1229.
20. Arbyn M, Sasieni P, Meijer CJ, Clavel C, Koliopoulos G, Dillner J. Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses. Vaccine. 2006;24(suppl 3):S78-S89. (Pubitemid 44293029)
21. Sherman ME, Castle PE, Solomon D. Cervical cytology of atypical squamous cells-cannot exclude high-grade squamous intraepithelial lesion (ASC-H): characteristics and histologic outcomes. Cancer. 2006;108(5):298-305. (Pubitemid 44583708)
22. Liman AK, Giampoli EJ, Bonfiglio TA. Should women with atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion, receive reflex human papillomavirus-DNA testing? Cancer. 2005;105(6):457-460.
23. Cox JT, Schiffman M, Solomon D, for the ASCUS-LSIL Triage Study (ALTS) Group. Prospective follow-up suggests similar risk of subsequent cervical intraepithelial neoplasia grade 2 or 3 among women with cervical intraepithelial neoplasia grade 1 or negative colposcopy and directed biopsy. Am J Obstet Gynecol. 2003;188(6):1406-1412.
24. ASCUS-LSIL Triage Study (ALTS) Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. Am J Obstet Gynecol. 2003;188(6):1393-1400. (Pubitemid 36741264)
25. Jones BA, Novis DA. Cervical biopsy-cytology correlation. A College of American Pathologists Q-Probes study of 22,439 correlations in 348 laboratories. Arch Pathol Lab Med. 1996;120(6):523-531.
26. Massed LS, Collins YC, Meyer PM. Biopsy correlates of abnormal cervical cytology classified using the Bethesda system. Gynecol Oncol. 2001;82(3):516-522.
27. DeSimone CP, Day ME, Tovar MM, Dietrich CS III, Eastham ML, Modesitt SC. Rate of pathology from atypical glandular cell Pap tests classified by the Bethesda 2001 nomenclature. Obstet Gynecol. 2006; 107(6):1285-1291.
28. Sharpless KE, Schnatz PF, Mandavilli S, Greene JF, Sorosky JI. Dysplasia associated with atypical glandular cells on cervical cytology [published correction appears in Obstet Gynecol. 2005;105(6):1495]. Obstet Gynecol. 2005;105(3):494-500.
29. Derchain SF, Rabelo-Santos SH, Sarian Lo, et al. Human papillomavirus DNA detection and histological findings in women referred for atypical glandular cells or adenocarcinoma in situ in their Pap smears. Gynecol Oncol. 2004;95(3):618-623. (Pubitemid 39592530)
30. Greenspan DL, Cardillo M, Davey DD, Heller DS, Moriarty AT. Endometrial cells in cervical cytology: review of cytological features and clinical assessment. J Low Genit Tract Dis. 2006;10(2):111-122. (Pubitemid 44259034)
31. Simsir A, Carter W, Elgert P, Cangiarella J. Reporting endometrial cells in women 40 years and older: assessing the clinical usefulness of Bethesda 2001. Am J Clin Pathol. 2005;123(4):571-575. (Pubitemid 40418552)
32. ostör AG. Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol. 1993;12(2):186-192.
33. Verguts J, Bronselaer B, Donders G, et al. Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation. BJOG. 2006;113(11):1303-1307. (Pubitemid 44581521)
34. Zielinski GD, Bais AG, Helmerhorst TJ, et al. HPV testing and monitoring of women after treatment of CIN 3: review of the literature and metaanalysis. Obstet Gynecol Surv. 2004;59(7):543-553. (Pubitemid 38802827)
35. Wang SS, Sherman ME, Hildesheim A, Lacey JV Jr, Devesa S. Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976-2000. Cancer. 2004;100(5):1035- 1044.
36. Soutter WP, Haidopoulos D, Gornall RJ, et al. Is conservative treatment for adenocarcinoma in situ of the cervix safe? BJOG. 2001; 108(11):1184-1189. (Pubitemid 33052484)
37. Azodi M, Chambers SK, Rutherford TJ, Kohorn EI, Schwartz PE, Chambers JT. Adenocarcinoma in situ of the cervix: management and outcome. Gynecol Oncol. 1999;73(3):348-353. (Pubitemid 29272853)
38. Winer RL, Lee SK, Hughes JP, Adam DE, Kiviat NB, Koutsky LA. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students [published correction appears in Am J Epidemiol. 2003;157(9):858]. Am J Epidemiol. 2003;157(3):218-226.
39. Moscicki AB, Ellenberg JH, Vermund SH, et al. Prevalence of and risks for cervical human papillomavirus infection and squamous intraepithelial lesions in adolescent girls: impact of infection with human immunodeficiency virus. Arch Pediatr Adolesc Med. 2000;154(2):127-134.
40. SEER Cancer Statistics Review 1975-2003. Bethesda, Md.: National Cancer Institute; 2006.
41. Green J, Berrington de Gonzalez A, Sweetland S, et al. Risk factors for adenocarcinoma and squamous cell carcinoma of the cervix in women aged 20-44 years: the UK National Case-Control Study of Cervical Cancer. Br J Cancer. 2003;89(11):2078-2086. (Pubitemid 38030906)
42. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med. 1998;338(7):423-428. (Pubitemid 28135669)
43. Evander M, Edlund K, Gustafsson A, et al. Human papillomavirus infection is transient in young women: a population-based cohort study. J Infect Dis. 1995;171(4):1026-1030.
44. Boardman LA, Stanko C, Weitzen S, Sung CJ. Atypical squamous cells of undetermined significance: human papillomavirus testing in adolescents. Obstet Gynecol. 2005;105(4):741-746. (Pubitemid 40432190)
45. Sadeghi SB, Hsieh EW, Gunn SW. Prevalence of cervical intraepithelial neoplasia in sexually active teenagers and young adults. Results of data analysis of mass Papanicolaou screening of 796,337 women in the United States in 1981. Am J Obstet Gynecol. 1984;148(6):726-729.
46. Bjørge T, Gunbjørud AB, Langmark F, Skare GB, Thoresen SO. Cervical mass screening in Norway-510,000 smears a year. Cancer Detect Prev. 1994;18(6):463-470.
47. Mount SL, Papillo JL. A study of 10,296 pediatric and adolescent Papanicolaou smear diagnoses in northern New England. Pediatrics. 1999;103(3):539-546.
48. Kyrgiou M, Koliopoulos G, Martin-Hirsch P, Arbyn M, Prendiville W, Paraskevaidis E. obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis. Lancet. 2006;367(9509):489-498. (Pubitemid 43208905)
49. Dunn TS, Bajaj JE, Stamm CA, Beaty B. Management of the minimally abnormal Papanicolaou smear in pregnancy. J Low Genit Tract Dis. 2001;5(3):133-137. (Pubitemid 33138305)
50. Paraskevaidis E, Koliopoulos G, Kalantaridou S, et al. Management and evolution of cervical intraepithelial neoplasia during pregnancy and postpartum. Eur J Obstet Gynecol Reprod Biol. 2002;104(1):67-69. (Pubitemid 34786395)
51. Yost NP, Santoso JT, McIntire DD, Iliya FA. Postpartum regression rates of antepartum cervical intraepithelial neoplasia II and III lesions. Obstet Gynecol. 1999;93(3):359-362.
52. Economos K, Perez Veridiano N, Delke I, Collado ML, Tancer ML. Abnormal cervical cytology in pregnancy: a 17-year experience. Obstet Gynecol. 1993;81(6):915-918. (Pubitemid 23168732)
53. Robinson WR, Webb S, Tirpack J, Degefu S, o'Quinn AG. Management of cervical intraepithelial neoplasia during pregnancy with LooP excision. Gynecol Oncol. 1997;64(1):153-155. (Pubitemid 27026974)